{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:54:09Z","timestamp":1791071649091,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jhep.2009.12.017","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T10:36:06Z","timestamp":1262946966000},"page":"616-619","source":"Crossref","is-referenced-by-count":107,"title":["The molecular basis of the failed immune response in chronic HBV: Therapeutic implications"],"prefix":"10.1016","volume":"52","author":[{"given":"Mala K.","family":"Maini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2009.12.017_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1473-3099(07)70264-5","article-title":"Therapeutic strategies in the management of patients with chronic hepatitis B virus infection","volume":"8","author":"Papatheodoridis","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2009.12.017_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/0016-5085(93)90664-X","article-title":"Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor","volume":"104","author":"Ilan","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.12.017_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib5","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2009.12.017_bib6","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.12.017_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/egh.09.48","article-title":"Therapeutic vaccination and novel strategies to treat chronic HBV infection","volume":"3","author":"Bertoletti","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.12.017_bib9","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib10","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.12.017_bib12","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","author":"Boni","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.12.017_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","article-title":"Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B","volume":"39","author":"Boni","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.12.017_bib14","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2009.12.017_bib15","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1128\/JVI.79.14.8960-8968.2005","article-title":"Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination","volume":"79","author":"Wherry","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib16","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2009.12.017_bib18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI33402","article-title":"Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection","volume":"118","author":"Lopes","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.12.017_bib19","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1128\/JVI.01075-08","article-title":"Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection","volume":"82","author":"Radziewicz","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1172\/JCI200421593","article-title":"The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity","volume":"114","author":"Bowen","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.12.017_bib22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2008.05.078","article-title":"Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death","volume":"135","author":"Holz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.12.017_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7\u2013H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2009.12.017_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.immuni.2005.05.005","article-title":"Oscillating CD8(+) T cell effector functions after antigen recognition in the liver","volume":"23","author":"Isogawa","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2009.12.017_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.12.017_bib26","doi-asserted-by":"crossref","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, et al. Anti-viral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2009 [Epub ahead of print].","DOI":"10.1053\/j.gastro.2009.09.052"},{"key":"10.1016\/j.jhep.2009.12.017_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"Penna","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.12.017_bib28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2009.12.017_bib29","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","volume":"50","author":"Kassel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.12.017_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ni1165","article-title":"Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4","volume":"6","author":"Probst","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2009.12.017_bib31","doi-asserted-by":"crossref","unstructured":"Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 2009;5:e1000313.","DOI":"10.1371\/journal.ppat.1000313"},{"key":"10.1016\/j.jhep.2009.12.017_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-specific immunity in vivo by PD-1 blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2009.12.017_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2009.12.017_bib34","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1073\/pnas.0306567101","article-title":"Costimulatory ligand 4\u20131BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses","volume":"101","author":"Bukczynski","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2009.12.017_bib36","doi-asserted-by":"crossref","unstructured":"Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, Liu Y, et al. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci USA 2006;103:18703\u201308.","DOI":"10.1073\/pnas.0602919103"},{"key":"10.1016\/j.jhep.2009.12.017_bib37","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.4049\/jimmunol.179.12.8252","article-title":"4\u20131BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2009.12.017_bib38","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection","volume":"205","author":"Das","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib40","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm866","article-title":"Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo","volume":"9","author":"Blattman","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1473-3099(07)70289-X","article-title":"T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies","volume":"7","author":"Manigold","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2009.12.017_bib42","doi-asserted-by":"crossref","unstructured":"Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 2007;81:5882\u201392.","DOI":"10.1128\/JVI.02202-06"},{"key":"10.1016\/j.jhep.2009.12.017_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","article-title":"Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo","volume":"31","author":"Tinoco","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2009.12.017_bib44","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.12.017_bib45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.12.017_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.20071949","article-title":"Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection","volume":"205","author":"Ha","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-065X.2008.00638.x","article-title":"Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections","volume":"223","author":"Ha","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2009.12.017_bib48","doi-asserted-by":"crossref","unstructured":"Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kurschner T, Schulze A, et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. Gastroenterology 2008;134:239\u201347.","DOI":"10.1053\/j.gastro.2007.11.002"},{"key":"10.1016\/j.jhep.2009.12.017_bib49","doi-asserted-by":"crossref","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126\u201329.","DOI":"10.1126\/science.1129003"},{"key":"10.1016\/j.jhep.2009.12.017_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2009.12.017_bib51","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.178.5.1541","article-title":"Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis","volume":"178","author":"Ando","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.12.017_bib52","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J Exp Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809008198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827809008198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T01:15:06Z","timestamp":1558746906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827809008198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0168827809008198"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2009.12.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}